CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zoetis Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zoetis Inc
10 Sylvan Way
Phone: (973) 822-7000p:973 822-7000 PARSIPPANY, NJ  07054  United States Ticker: ZTSZTS
Business Summary
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. It is engaged in commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes-YesYes

Industries
SIC Code Description
2834 Pharmaceutical preparations
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board Michael B.Mccallister 71 1/1/2015 1/1/2013
Chief Executive Officer, Director Kristin C.Peck 52 1/1/2020 10/1/2012
Chief Financial Officer, Executive Vice President Wetteny N.Joseph 51 6/1/2021 6/1/2021
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
CROSS VETPHARM GROUP LIMITED 2ND FLOOR BUILDING 10 CHERRYWOOD BUSINESS PARK IE
VIRTUAL RECALL LIMITED 7 HUXLEY ROAD SURREY RESEARCH PARK UK
ZOETIS UK LIMITED FIRST FLOOR, BIRCHWOOD BUILDING SPRINGFIELD DRIVE UK
25 additional Subsidiary records available in full report.

Business Names
Business Name
Abaxis Europe GmbH
Abaxis Inc
Adivo GmbH
125 additional Business Names available in full report.

General Information
Number of Employees: 14,100 (As of 12/31/2023)
Outstanding Shares: 451,165,011 (As of 10/31/2024)
Shareholders: 1,574
Stock Exchange: NYSE
Federal Tax Id: 460696167
Fax Number: (302) 655-5049


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024